My site

 Policy further strengthens Takeda’s commitment to best-in-class corporate governance

OSAKA, Japan-Friday 3 April 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced that its Board of Directors approved an executive compensation recoupment policy (“clawback policy”). The adoption of the clawback policy is part of Takeda’s ongoing efforts to further strengthen its commitment to best-in-class corporate governance and is consistent with Takeda’s industry peers.

The clawback policy provides that in the event of a significant restatement of financial results or significant misconduct, the independent external members of Takeda’s Board of Directors may require Takeda to recoup incentive compensation. This would include all or a portion of the compensation received by any member of the Takeda Executive Team, any Internal Direct ... Read more »

Organizations racing to protect sensitive data as it proliferates across cloud, IoT devices and 5G networks

MINNEAPOLIS & CAMBRIDGE, England-Tuesday 7 April 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- As organizations accelerate digital initiatives such as cloud and the internet of things (IoT), and data volumes and types continue to rise, IT professionals cite protection of customer personal information as their number one priority, according to the 2020 Global Encryption Trends Study from the Ponemon Institute.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200407005297/en/

The Ponemon Institute has collaborated with nCipher Security, an Entrust Datacard company and world leader in hardware security modules (HSMs), on this multinational survey of how and why organizations deploy encryption, now in its fifteenth year.

Threats, drivers and priorities

For the first time, protec ... Read more »

LES ULIS, France-Tuesday 7 April 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- LFB today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) 2061 for SEVENFACT®, a new recombinant coagulation Factor VIIa [coagulation factor VIIa (recombinant)-jncw], for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with Hemophilia A or B with inhibitors (neutralizing antibodies). An exclusive license for the commercialization of the product in the USA and Canada has been granted to HEMA Biologics, a joint venture between LFB and US WorldMeds.

Denis Delval LFB’s Chairman and Chief Executive Officer, stated: “We are very pleased with the FDA approval of SEVENFACT® which provides a new treatment option for hemophilia patients. This approval is a validation of an innovative LFB technology. We will now work towards SEVENFACT® registration in Europe and o ... Read more »

DMS launches its “Lead Collection Solution”

North Africa

ADDIS ABABA, Ethiopia -Tuesday 7 April 2020 [ AETOS Wire ]

ANPI is the Jack Ma Foundation’s flagship philanthropic program in Africa, and aims to give entrepreneurs across Africa a platform to develop their talent and business ideas, and inspire others to pursue entrepreneurship
Now in its second year, the Africa’s Business Heroes (ABH) prize competition will open applications in French and English, and award a pool of US$1.5 million in grant money to ten finalists
Open to entrepreneurs across all sectors and African countries, ABH has a special focus on those building up their local communities and working to solve the most pressing problems
(BUSINESS WIRE)-- The Jack Ma Foundation announced today it has officially launched the second edition of the “Africa’s Business Heroes” (ABH) prize competition with applications now open to African entrepreneurs from all 54 African countries, as well as every sector, ... Read more »

ZeBrand announces the official global launch of its A.I. brand identity automation service for startups and small businesses worldwide.